https://pubmed.ncbi.nlm.nih.gov/38641828/?dopt=Abstract
N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via...
Taken together, m6A-modified circSLCO1B3 was correlated with poor prognosis in ICC and promoted ICC progression not only by enhancing proliferation and...
modifiedpromotescholangiocarcinomaprogressionvia